Toward the Prediction of FBPase Inhibitory Activity Using Chemoinformatic Methods

被引:5
作者
Hao, Ming [1 ]
Zhang, Shuwei [1 ]
Qiu, Jieshan [1 ]
机构
[1] Dalian Univ Technol, Dept Mat Sci & Chem Engn, Dalian 116023, Liaoning, Peoples R China
关键词
FBPase inhibitor; chemoinformatics methods; genetic algorithm; random forest; CHANNEL ANTAGONIST ACTIVITY; GENETIC ALGORITHM; FRUCTOSE 1,6-BISPHOSPHATASE; VARIABLE SELECTION; MOLECULAR-DYNAMICS; RANDOM FOREST; QSAR; FRUCTOSE-1,6-BISPHOSPHATASE; REGRESSION; POTENT;
D O I
10.3390/ijms13067015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Currently, Chemoinformatic methods are used to perform the prediction for FBPase inhibitory activity. A genetic algorithm-random forest coupled method (GA-RF) was proposed to predict fructose 1,6-bisphosphatase (FBPase) inhibitors to treat type 2 diabetes mellitus using the Mold(2) molecular descriptors. A data set of 126 oxazole and thiazole analogs was used to derive the GA-RF model, yielding the significant non-cross-validated correlation coefficient r(ncv)(2) and cross-validated r(cv)(2) values of 0.96 and 0.67 for the training set, respectively. The statistically significant model was validated by a test set of 64 compounds, producing the prediction correlation coefficient r(pred)(2) of 0.90. More importantly, the building GA-RF model also passed through various criteria suggested by Tropsha and Roy with r(o)(2) and r(m)(2) values of 0.90 and 0.83, respectively. In order to compare with the GA-RF model, a pure RF model developed based on the full descriptors was performed as well for the same data set. The resulting GA-RF model with significantly internal and external prediction capacities is beneficial to the prediction of potential oxazole and thiazole series of FBPase inhibitors prior to chemical synthesis in drug discovery programs.
引用
收藏
页码:7015 / 7037
页数:23
相关论文
共 52 条
[1]  
*ACC INC, 2001, CER VERS 4 6
[2]  
Bailey C.J., 1996, NEW ENGL J MED, V334, P5745
[3]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[4]   Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes [J].
Dang, Qun ;
Kasibhatla, Srinivas Rao ;
Reddy, K. Raja ;
Jiang, Tao ;
Reddy, M. Rami ;
Potter, Scott C. ;
Fujitaki, James M. ;
van Poelje, Paul D. ;
Huang, Jingwei ;
Lipscomb, William N. ;
Erion, Mark D. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (50) :15491-15502
[5]   Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity [J].
Dang, Qun ;
Kasibthatla, Srinivas Rao ;
Jiang, Tao ;
Taplin, Frank ;
Gibson, Tony ;
Potter, Scott C. ;
van Poelje, Paul D. ;
Erion, Mark D. .
MEDCHEMCOMM, 2011, 2 (04) :287-290
[6]   Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase [J].
Dang, Qun ;
Liu, Yan ;
Cashion, Daniel K. ;
Kasibhatla, Srinivas Rao ;
Jiang, Tao ;
Taplin, Frank ;
Jacintho, Jason D. ;
Li, Haiqing ;
Sun, Zhili ;
Fan, Yi ;
DaRe, Jay ;
Tian, Feng ;
Li, Wenyu ;
Gibson, Tony ;
Lemus, Robert ;
van Poelje, Paul D. ;
Potter, Scott C. ;
Erion, Mark D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) :153-165
[7]   Fructose-1,6-bisphosphatase Inhibitors. 2. Design, Synthesis, and Structure-Activity Relationship of a Series of Phosphonic Acid Containing Benzimidazoles that Function as 5′-Adenosinemonophosphate (AMP) Mimics [J].
Dang, Qun ;
Kasibhatla, Srinivas Rao ;
Xiao, Wei ;
Liu, Yan ;
DaRe, Jay ;
Taplin, Frank ;
Reddy, K. Raja ;
Scarlato, Gerard R. ;
Gibson, Tony ;
van Poelje, Paul D. ;
Potter, Scott C. ;
Erion, Mark D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (01) :441-451
[8]   Fructose-1,6-bisphosphatase Inhibitors. 1. Purine Phosphonic Acids as Novel AMP Mimics [J].
Dang, Qun ;
Brown, Brian S. ;
Liu, Yan ;
Rydzewski, Robert M. ;
Robinson, Edward D. ;
van Poelje, Paul D. ;
Reddy, M. Rami ;
Erion, Mark D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) :2880-2898
[9]   Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations [J].
Durdagi, Serdar ;
Mavromoustakos, Thomas ;
Chronakis, Nikos ;
Papadopoulos, Manthos G. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (23) :9957-9974
[10]   MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes [J].
Erion, MD ;
van Poelje, PD ;
Dang, Q ;
Kasibhatla, SR ;
Potter, SC ;
Reddy, MR ;
Reddy, KR ;
Jiang, T ;
Lipscomb, WN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (22) :7970-7975